• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定抑制阴道毛滴虫尿苷核苷核糖水解酶的质子泵抑制剂药物。

Identification of proton-pump inhibitor drugs that inhibit Trichomonas vaginalis uridine nucleoside ribohydrolase.

机构信息

Department of Chemistry, Adelphi University, 1 South Avenue, Garden City, NY 11530, United States.

Department of Chemistry, Adelphi University, 1 South Avenue, Garden City, NY 11530, United States.

出版信息

Bioorg Med Chem Lett. 2014 Feb 15;24(4):1080-4. doi: 10.1016/j.bmcl.2014.01.014. Epub 2014 Jan 13.

DOI:10.1016/j.bmcl.2014.01.014
PMID:24468412
Abstract

Trichomonas vaginalis continues to be a major health problem with drug-resistant strains increasing in prevalence. Novel antitrichomonal agents that are mechanistically distinct from current therapies are needed. The NIH Clinical Compound Collection was screened to find inhibitors of the uridine ribohydrolase enzyme required by the parasite to scavenge uracil for its growth. The proton-pump inhibitors omeprazole, pantoprazole, and rabeprazole were identified as inhibitors of this enzyme, with IC50 values ranging from 0.3 to 14.5 μM. This suggests a molecular mechanism for the in vitro antitrichomonal activity of these proton-pump inhibitors, and may provide important insights toward structure-based drug design.

摘要

阴道毛滴虫仍然是一个主要的健康问题,具有耐药性的菌株越来越普遍。需要新型的、与现有治疗方法在机制上不同的抗滴虫药物。美国国立卫生研究院临床化合物库被筛选,以寻找寄生虫生长所需的尿苷核糖水解酶的抑制剂。质子泵抑制剂奥美拉唑、泮托拉唑和雷贝拉唑被鉴定为该酶的抑制剂,IC50 值范围为 0.3 至 14.5 μM。这表明这些质子泵抑制剂在体外抗滴虫活性的分子机制,并可能为基于结构的药物设计提供重要的见解。

相似文献

1
Identification of proton-pump inhibitor drugs that inhibit Trichomonas vaginalis uridine nucleoside ribohydrolase.鉴定抑制阴道毛滴虫尿苷核苷核糖水解酶的质子泵抑制剂药物。
Bioorg Med Chem Lett. 2014 Feb 15;24(4):1080-4. doi: 10.1016/j.bmcl.2014.01.014. Epub 2014 Jan 13.
2
Antiprotozoal activity of proton-pump inhibitors.质子泵抑制剂的抗原生动物活性。
Bioorg Med Chem Lett. 2011 Dec 15;21(24):7351-4. doi: 10.1016/j.bmcl.2011.10.028. Epub 2011 Oct 14.
3
Adenosine/guanosine preferring nucleoside ribohydrolase is a distinct, druggable antitrichomonal target.腺苷/鸟苷偏好性核苷核糖水解酶是一个独特的、可成药的抗滴虫靶点。
Bioorg Med Chem Lett. 2015 Nov 15;25(22):5036-9. doi: 10.1016/j.bmcl.2015.10.030. Epub 2015 Oct 22.
4
Ligand-Efficient Inhibitors of Trichomonas vaginalis Adenosine/Guanosine Preferring Nucleoside Ribohydrolase.阴道毛滴虫腺苷/鸟苷偏好性核苷核糖水解酶的配体高效抑制剂
ACS Infect Dis. 2019 Mar 8;5(3):345-352. doi: 10.1021/acsinfecdis.8b00346. Epub 2019 Feb 1.
5
[In vitro susceptibility of Trichomonas vaginalis to metronidazole, ornidazole and proton pump inhibitors pantoprazole and esomeprazole].阴道毛滴虫对甲硝唑、奥硝唑以及质子泵抑制剂泮托拉唑和埃索美拉唑的体外敏感性
Mikrobiyol Bul. 2016 Jan;50(1):133-9.
6
Druggability of the guanosine/adenosine/cytidine nucleoside hydrolase from Trichomonas vaginalis.阴道毛滴虫的鸟苷/腺苷/胞苷核苷水解酶的可药性。
Chem Biol Drug Des. 2018 Oct;92(4):1736-1742. doi: 10.1111/cbdd.13341. Epub 2018 Jun 19.
7
Recent advances in chirally pure proton pump inhibitors.手性纯质子泵抑制剂的最新进展。
J Indian Med Assoc. 2007 Aug;105(8):469-70, 472, 474.
8
Negative chronotropic effect of proton pump inhibitors on frog-heart preparation.质子泵抑制剂对蛙心标本的负性变时作用。
Indian J Gastroenterol. 2009 Jul-Aug;28(4):147-9. doi: 10.1007/s12664-009-0052-x. Epub 2009 Nov 24.
9
Proton pump inhibitors selectively suppress MLL rearranged leukemia cells via disrupting MLL1-WDR5 protein-protein interaction.质子泵抑制剂通过破坏 MLL1-WDR5 蛋白-蛋白相互作用,选择性地抑制 MLL 重排白血病细胞。
Eur J Med Chem. 2020 Feb 15;188:112027. doi: 10.1016/j.ejmech.2019.112027. Epub 2019 Dec 31.
10
Repurposing of Proton Pump Inhibitors as first identified small molecule inhibitors of endo-β-N-acetylglucosaminidase (ENGase) for the treatment of NGLY1 deficiency, a rare genetic disease.质子泵抑制剂被重新用作首次鉴定出的内切-β-N-乙酰氨基葡萄糖苷酶(ENGase)小分子抑制剂,用于治疗一种罕见的遗传疾病——NGLY1缺乏症。
Bioorg Med Chem Lett. 2017 Jul 1;27(13):2962-2966. doi: 10.1016/j.bmcl.2017.05.010. Epub 2017 May 5.

引用本文的文献

1
In vitro susceptibility testing of Trichomonas gallinae strains to proton pump inhibitors and nitroimidazoles.鸡三毛滴虫菌株对质子泵抑制剂和硝基咪唑类药物的体外药敏试验。
Sci Rep. 2025 Jul 8;15(1):24437. doi: 10.1038/s41598-025-10668-w.
2
Direct Measurement of Nucleoside Ribohydrolase Enzyme Activities in Cells Using F and C-Edited H NMR Spectroscopy.使用 F 和 C-编辑的 H NMR 光谱法直接测量细胞中的核苷核糖水解酶活性。
Anal Chem. 2023 Mar 28;95(12):5300-5306. doi: 10.1021/acs.analchem.2c05330. Epub 2023 Mar 14.
3
Structure-Guided Insight into the Specificity and Mechanism of a Parasitic Nucleoside Hydrolase.
基于结构的寄生虫核苷水解酶特异性和作用机制的深入了解。
Biochemistry. 2022 Sep 6;61(17):1853-1861. doi: 10.1021/acs.biochem.2c00361. Epub 2022 Aug 22.
4
F NMR viewed through two different lenses: ligand-observed and protein-observed F NMR applications for fragment-based drug discovery.通过两种不同视角看待氟核磁共振:基于片段药物发现中配体观测和蛋白质观测的氟核磁共振应用。
RSC Chem Biol. 2021 Jul 12;2(5):1312-1330. doi: 10.1039/d1cb00085c. eCollection 2021 Oct 7.
5
Discovery of Ligand-Efficient Scaffolds for the Design of Novel Uridine Nucleoside Ribohydrolase Inhibitors Using Fragment Screening.利用片段筛选发现用于设计新型尿苷核苷核糖水解酶抑制剂的配体高效骨架
ACS Omega. 2019 Sep 16;4(14):16226-16232. doi: 10.1021/acsomega.9b02472. eCollection 2019 Oct 1.
6
NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases.基于核磁共振的活性测定法,用于确定核苷核糖水解酶的化合物抑制作用、半数抑制浓度值、假活性和全细胞活性。
J Vis Exp. 2019 Jun 30(148). doi: 10.3791/59928.
7
Ligand-Efficient Inhibitors of Trichomonas vaginalis Adenosine/Guanosine Preferring Nucleoside Ribohydrolase.阴道毛滴虫腺苷/鸟苷偏好性核苷核糖水解酶的配体高效抑制剂
ACS Infect Dis. 2019 Mar 8;5(3):345-352. doi: 10.1021/acsinfecdis.8b00346. Epub 2019 Feb 1.
8
Druggability of the guanosine/adenosine/cytidine nucleoside hydrolase from Trichomonas vaginalis.阴道毛滴虫的鸟苷/腺苷/胞苷核苷水解酶的可药性。
Chem Biol Drug Des. 2018 Oct;92(4):1736-1742. doi: 10.1111/cbdd.13341. Epub 2018 Jun 19.
9
Thiopurine Drugs Repositioned as Tyrosinase Inhibitors.硫唑嘌呤类药物被重新定位为酪氨酸酶抑制剂。
Int J Mol Sci. 2017 Dec 28;19(1):77. doi: 10.3390/ijms19010077.
10
Proton pump inhibitors are associated with a reduced likelihood for sexually transmitted diseases in women in the emergency department.质子泵抑制剂与急诊科女性性传播疾病的发病可能性降低有关。
Indian J Sex Transm Dis AIDS. 2017 Jan-Jun;38(1):60-64. doi: 10.4103/0253-7184.203438.